Loading...

Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?

In a group of 74 patients with advanced metastatic breast cancer, 57% of those with cytoplasmic oestrogen receptor activity in their tumours (REC+) showed a clinical response to endocrine therapy. Of 51 patients whose tumour was assayed for both REC and cytoplasmic progesterone (RPC) activity, 9/12...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Barnes, D. M., Skinner, L. G., Ribeiro, G. G.
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 1979
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010127/
https://ncbi.nlm.nih.gov/pubmed/230853
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!